Edward David Crandall, PhD, MD

Professor of Pathology

Hasting Foundation Professorship in Medicine

Director of the Will Rogers Institute Pulmonary Research Center

Image of Edward David Crandall, PhD, MD
Is this your profile? Click to edit

Overview

Dr. Crandall’s research has been focused on the following topics: markers of alveolar epithelial cell development and differentiation, regulation of pulmonary epithelial cell differentiation, acute and chronic lung injury and the factors that influence recovery, transport properties of pulmonary alveolar epithelium, and biology of nanoparticle interactions with alveolar epithelial cells.

Dr. Crandall received his B.Ch.E. from Cooper Union, his M.S. and Ph.D. in chemical engineering from Northwestern University, and his M.D. from the University of Pennsylvania. His training in internal medicine and pulmonary/critical care medicine was undertaken at the Hospital of the University of Pennsylvania.

Awards

  • Best Doctors of America, 2005
     – Pres
  • National Institutes of Health: MERIT Award, 1987
     – 1997
  • National Institutes of Health: Research Career Development Award, 1975
     – 1980
  • University of Pennsylvania: Chair of Department of Medicine Scholarship
  • U.S. Public Health Service: Special Fellowship
  • National Science Foundation: Graduate Fellowship
  • New York State: Regents Scholarship

Research Funding

  • MAPGen Knowledge Base (MAPGenKB) and Coordination Center
    NIH · U01HL108634 · Aug 25, 2011 – May 31, 2018 · Role: Co-Principal Investigator
  • Interactions of engineered nanomaterials with lung alveolar epithelium
    NIH · RC2ES018782 · Sep 25, 2009 – Jun 30, 2012 · Role: Principal Investigator
  • Nanoparticle properties and alveolar epithelial barrier/transport functions
    NIH · R01ES017034 · Jun 15, 2009 – Mar 31, 2015 · Role: Principal Investigator
  • Absorption mechanisms for peptide/protein drugs via lung
    NIH · R01HL064365 · Sep 30, 1999 – Jul 31, 2010 · Role: Principal Investigator
  • AT1 vs AT2 cells: differential roles in alveolar function and biology
    NIH · R01HL038621 · Sep 1, 1986 – Jun 30, 2012 · Role: Principal Investigator
  • GATA-6: Key Regulator of AEC Transdifferentiation
    NIH · R01HL038578 · Sep 1, 1986 – Nov 30, 2008 · Role: Co-Principal Investigator
  • LUNG EPITHELIAL TRANSPORT PROPERTIES AND ALVEOLAR EDEMA
    NIH · R37HL038578 · Sep 1, 1986 – Aug 31, 1997 · Role: Principal Investigator
  • DETERMINANTS OF LUNG AND TISSUE CO2 EXCHANGE AND TRANSPO
    NIH · R01HL025669 · Aug 1, 1980 – Aug 31, 1986 · Role: Principal Investigator
  • LUNG EPITHELIAL TRANSPORT PROPERTIES AND ALVEOLAR EDEMA
    NIH · R01HL026223 · Aug 1, 1980 – Aug 31, 1986 · Role: Principal Investigator

Publications

  • Increased lung cell susceptibility to injury due to autophagic overload after exposure to nanoparticles. Am J Physiol Lung Cell Mol Physiol. 2026 Aug 01; 331(2):L197-L205.. View in PubMed
  • Claudin 4 Deletion Improves Gut Permeability and Survival in a Murine Model of Abdominal Sepsis. Shock. 2026 Apr 01; 65(4):710-726.. View in PubMed
  • In-house Fabrication of Nanoplastics of Tunable Composition and Application: Assessment of Bioelectric Changes in Primary Rat Lung Alveolar Epithelial Cell Monolayers Exposed to Nanoplastics. Bio Protoc. 2025 Jun 05; 15(11):e5329.. View in PubMed
  • Real-Time Autophagic Flux Measurements in Live Cells Using a Novel Fluorescent Marker DAPRed. Bio Protoc. 2024 Mar 05; 14(5):e4949.. View in PubMed
  • Kinetics of autophagic activity in nanoparticle-exposed lung adenocarcinoma (A549) cells. Autophagy Rep. 2023; 2(1).. View in PubMed
  • Characteristics of Passive Solute Transport across Primary Rat Alveolar Epithelial Cell Monolayers. Membranes (Basel). 2021 Apr 30; 11(5).. View in PubMed
  • Biokinetic modeling of nanoparticle interactions with lung alveolar epithelial cells: uptake, intracellular processing, and egress. Am J Physiol Regul Integr Comp Physiol. 2021 01 01; 320(1):R36-R43.. View in PubMed
  • Epithelial Vegfa Specifies a Distinct Endothelial Population in the Mouse Lung. Dev Cell. 2020 03 09; 52(5):617-630.e6.. View in PubMed
  • Evidence for Nanoparticle-Induced Lysosomal Dysfunction in Lung Adenocarcinoma (A549) Cells. Int J Mol Sci. 2019 Oct 23; 20(21).. View in PubMed
  • Transcriptional control of lung alveolar type 1 cell development and maintenance by NK homeobox 2-1. Proc Natl Acad Sci U S A. 2019 10 08; 116(41):20545-20555.. View in PubMed